Inventor · disambiguated record
Adegoke O. Adeniji
Also filed as: ADENIJI ADEGOKE · ADENIJI ADEGOKE O
7 granted patents·2 pending applications·13 citations·filing 2012–2022
80Inventor score
Top patents by PatentIndex Score
9 records- 0189US9895351B2Indomethacin analogs for the treatment of castrate-resistant prostate cancerUNIV VANDERBILT·Filed 2016·Granted Feb 20, 2018·4 cites·14 claims
- 0286US10398678B2Indomethacin analogs for the treatment of castrate-resistant prostate cancerUNIV VANDERBILT·Filed 2018·Granted Sep 3, 2019·2 cites·14 claims
- 0386US9346803B2Indomethacin analogs for the treatment of castrate-resistant prostate cancerUNIV VANDERBILT·Filed 2012·Granted May 24, 2016·4 cites·10 claims
- 0477US11459295B22-beta-naphthyl-acetic acid analogs as AKR1C3 inhibitors and methods of using sameUNIV PENNSYLVANIA·Filed 2016·Granted Oct 4, 2022·1 cites·17 claims
- 0577US9271961B2Bifunctional AKR1C3 inhibitors/androgen receptor modulators and methods of use thereofUNIV PENNSYLVANIA·Filed 2013·Granted Mar 1, 2016·2 cites·12 claims
- 0673US11738004B2Indomethacin analogs for the treatment of castrate-resistant prostate cancerUNIV VANDERBILT·Filed 2021·Granted Aug 29, 2023·0 cites·14 claims
- 0769US2023039244A12-beta-naphthyl-acetic acid analogs as akr1c3 inhibitors and methods of using sameUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 0867US2019350903A1Indomethacin analogs for the treatment of castrate-resistant prostate cancerUNIV VANDERBILT·Filed 2019·Application pending·0 cites
- 0958US10071953B2Bifunctional AKR1C3 inhibitors/androgen receptor modulators and methods of use thereofUNIV PENNSYLVANIA·Filed 2016·Granted Sep 11, 2018·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Adegoke O. Adeniji files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →